Đang chuẩn bị liên kết để tải về tài liệu:
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients

Biochemical recurrence (BCR) after initial treatment, such as radical prostatectomy, is the most frequently adopted prognostic factor for patients who suffer from prostate cancer (PCa). In this study, we aimed to construct a prognostic model consisting of gene expression profiles to predict BCR-free survival. |